Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Acceptance and Commitment Therapy for Smoking Cessation and Reduction of Psychotic Symptoms in Patients With Schizophrenia

NCT07441928 is registered in ClinicalTrials.gov with The Hong Kong Polytechnic University as lead sponsor.

NCT NCT07441928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07441928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using Functional Magnetic Resonance Imaging (fMRI) to Assess the Effects of Acceptance and Commitment Therapy for Smoking Cessation and Reduction of Psychotic Symptoms in Patients With Schizophrenia
Lead sponsor
The Hong Kong Polytechnic University
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2023
Completion date
April 30, 2026
Enrollment
90 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

schizophenia disorder, smoking cessation